Geode Capital Management’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Sell |
396,626
-465,273
| -54% | -$540K | ﹤0.01% | 3582 |
|
|
2025
Q1 | $948K | Sell |
861,899
-8,656
| -1% | -$9.52K | ﹤0.01% | 3322 |
|
|
2024
Q4 | $1.5M | Buy |
870,555
+6,027
| +0.7% | +$10.4K | ﹤0.01% | 3229 |
|
|
2024
Q3 | $2.14M | Buy |
864,528
+52,395
| +6% | +$130K | ﹤0.01% | 3105 |
|
|
2024
Q2 | $1.97M | Buy |
812,133
+526,994
| +185% | +$1.28M | ﹤0.01% | 3133 |
|
|
2024
Q1 | $1.16M | Buy |
285,139
+20,536
| +8% | +$83.2K | ﹤0.01% | 3318 |
|
|
2023
Q4 | $1.02M | Hold |
264,603
| – | – | ﹤0.01% | 3347 |
|
|
2023
Q3 | $1.1M | Buy |
264,603
+97,783
| +59% | +$406K | ﹤0.01% | 3282 |
|
|
2023
Q2 | $802K | Hold |
166,820
| – | – | ﹤0.01% | 3439 |
|
|
2023
Q1 | $677K | Hold |
166,820
| – | – | ﹤0.01% | 3534 |
|
|
2022
Q4 | $900K | Buy |
166,820
+9,175
| +6% | +$49.5K | ﹤0.01% | 3391 |
|
|
2022
Q3 | $1.58M | Buy |
157,645
+48,796
| +45% | +$489K | ﹤0.01% | 3171 |
|
|
2022
Q2 | $511K | Sell |
108,849
-233,797
| -68% | -$1.1M | ﹤0.01% | 3744 |
|
|
2022
Q1 | $1.34M | Buy |
342,646
+170,767
| +99% | +$667K | ﹤0.01% | 3473 |
|
|
2021
Q4 | $1.16M | Buy |
171,879
+64,073
| +59% | +$433K | ﹤0.01% | 3643 |
|
|
2021
Q3 | $1.6M | Buy |
+107,806
| New | +$1.6M | ﹤0.01% | 3457 |
|